
Company valuation, historical trends, and peer comparisons.
According to WuXi Biologics (Cayman) Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 187.32B. This represents a change of 93.79% compared to the average of 96.66B of the last 4 quarters.
The mean historical Enterprise Value of WuXi Biologics (Cayman) Inc. over the last ten years is 142.06B. The current 187.32B Enterprise Value has changed 31.86% with respect to the historical average. Over the past ten years (40 quarters), WXXWY's Enterprise Value was at its highest in in the June 2021 quarter at 512.04B. The Enterprise Value was at its lowest in in the January 2014 quarter at 0.
Average
142.06B
Median
109.18B
Minimum
29.64B
Maximum
357.44B
Discovering the peaks and valleys of WuXi Biologics (Cayman) Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 215.19%
Maximum Annual Enterprise Value = 357.44B
Minimum Annual Increase = -51.24%
Minimum Annual Enterprise Value = 29.64B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 111.80B | 74.74% |
| 2024 | 63.98B | -39.95% |
| 2023 | 106.56B | -51.24% |
| 2022 | 218.55B | -33.16% |
| 2021 | 326.98B | -8.52% |
| 2020 | 357.44B | 215.19% |
| 2019 | 113.40B | 111.04% |
| 2018 | 53.74B | 39.35% |
| 2017 | 38.56B | 30.12% |
| 2016 | 29.64B | 9.31% |
The current Enterprise Value of WuXi Biologics (Cayman) Inc. (WXXWY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
94.12B
5-year avg
165.57B
10-year avg
142.06B
WuXi Biologics (Cayman) Inc.’s Enterprise Value is less than WuXi AppTec Co., Ltd. (339.44B), greater than WuXi XDC Cayman Inc (76.44B), less than Samsung Biologics Co.,Ltd. (71.67T), greater than Lonza Group AG (49.89B), greater than Charles River Laboratories International, Inc. (18.37B), greater than Genscript Biotech Corporation (9.67B), greater than Pharmaron Beijing Co., Ltd. (72.90B), greater than Asymchem Laboratories (Tianjin) Co., Ltd. (46.24B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 339.44B | $71.48B | |
| 76.44B | $91.18B | |
| 71.67T | $70.71T | |
| 49.89B | $57.95B | |
| 18.37B | $15.72B | |
| 9.67B | $10.12B | |
| 72.90B | $68.56B | |
| 46.24B | $49.73B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like WuXi Biologics (Cayman) Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like WuXi Biologics (Cayman) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is WuXi Biologics (Cayman) Inc.'s Enterprise Value?
What is the highest Enterprise Value for WuXi Biologics (Cayman) Inc. (WXXWY)?
What is the 3-year average Enterprise Value for WuXi Biologics (Cayman) Inc. (WXXWY)?
What is the 5-year average Enterprise Value for WuXi Biologics (Cayman) Inc. (WXXWY)?
How does the current Enterprise Value for WuXi Biologics (Cayman) Inc. (WXXWY) compare to its historical average?